MétaCan
Menu
Back to cohort

Hypertension and beta-blocker use as prognostic and predictive factors in metastatic colorectal cancer: A retrospective analysis of NCIC CTG CO.17.

2016· article· en· W2891420311 on OpenAlexaff
Shelly Sud, Christopher J. O’Callaghan, Christos S. Karapetis, Caleb Jonker, Timothy Price, Niall C. Tebbutt, Jeremy Shapiro, Guy A. Van Hazel, Nick Pavlakis, Peter Gibbs, Mark Jeffery, Lillian L. Siu, Sharlene Gill, Ralph Wong, Derek J. Jonker, Dongsheng Tu, Rachel Goodwin

Bibliographic record

VenueJournal of Clinical Oncology · 2016
Typearticle
Languageen
FieldMedicine
TopicCancer, Stress, Anesthesia, and Immune Response
Canadian institutionsQueen's UniversityCancerCare ManitobaBC Cancer AgencyOttawa HospitalPrincess Margaret Cancer CentreUniversity of Ottawa
Fundersnot available
KeywordsMedicineColorectal cancerCetuximabInternal medicineOncologyProportional hazards modelMultivariate analysisCancerPanitumumabRefractory (planetary science)ChemotherapyProgression-free survivalUnivariate analysis

Abstract

fetched live from OpenAlex

e15025 Background: Adrenergic receptor stimulation is involved in the development of hypertension (HTN), and has been implicated in progression and dissemination of metastases in various tumours including colon cancer. Furthermore adrenergic antagonists, such as beta-blockers (BB), demonstrate inhibition of invasion and migration in colon cancer cell lines and have been associated with decreased mortality in colorectal cancer. We examined the association of baseline HTN (bHTN) and use of BB on overall (OS) or progression-free survival (PFS) of pts with pre-treated, chemotherapy refractory, metastatic colorectal cancer (mCRC). We also examined bHTN as a predictor of Cetuximab (CET) efficacy. Methods: Using data from NCIC CO.17 (CET vs. BSC), we coded bHTN and use of anti-HTN medications (Rx), including BB, for 572 pts. Chi-square test was used to assess association between these variables and baseline characteristics. Univariate and multivariate analyses of OS and PFS by bHTN and BB use were performed using Cox regression models. Results: Pts with bHTN (149/572) and those using BB (60/572) were older, had diminished performance status, and higher creatinine levels. bHTN, BB use and anti-HTN Rx use were not found to be prognostic for improved OS and PFS, though a trend towards significance was noted between BB use and improved PFS (HR 1.38 [0.97- 1.96], p= 0.077). bHTN and BB use were not significant predictors of CET benefit. However, pts with bHTN tended to have a stronger treatment effect in PFS from CET (interaction p = 0.074). Conclusions: In chemo-refractory mCRC, neither bHTN nor BB use is a significant prognostic factor. bHTN and BB use are not predictive factors for CET benefit, though pts with bHTN may benefit from a stronger treatment effect with CET. Patients who are chemo-refractory may be biologically selected and the impact of BB use in earlier lines may thus still warrant investigation. Predictive effects of bHTN. Interaction HR (CET vs BSC) (95% CI) [p-value] HR (95% CI) [p-value] OS bHTN 0.67 (0.45-0.98) [0.038] 1.20 (0.77-1.86) [0.418] No-bHTN 0.77 (0.62 -0.95) [0.015] PFS bHTN 0.49 (0.34-0.69) [<0.0001] 1.43 (0.97-2.11) [0.074] No-bHTN 0.75 (0.62-0.92) [0.005]

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.053
Threshold uncertainty score0.106

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.003
Science and technology studies0.0010.000
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.082
GPT teacher head0.415
Teacher spread0.334 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicCancer, Stress, Anesthesia, and Immune ResponseFrench-language works237,207